Key Financial Data Of Group

K Pharma,Inc. - Filing #7344418

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2019-11-01 to
2020-12-31
As at
2020-12-31
As at
2019-10-31
2018-11-01 to
2019-10-31
Key financial data of group
Business results of group
Net sales
1,000,000,000 JPY
JPY
JPY
JPY
JPY
Ordinary profit (loss)
344,184,000 JPY
-359,233,000 JPY
-220,892,000 JPY
-269,562,000 JPY
-255,606,000 JPY
Net assets
3,104,768,000 JPY
1,336,263,000 JPY
178,891,000 JPY
8,009,000 JPY
279,228,000 JPY
Total assets
3,313,902,000 JPY
1,374,566,000 JPY
205,767,000 JPY
56,983,000 JPY
294,068,000 JPY
Net assets per share
267.55
-122.77
-107.03
-84,539.31
-45,788.18
Basic earnings (loss) per share
25.42
-42.06
-30.09
-38,751.13
-37,032.98
Diluted earnings per share
23.07
Equity-to-asset ratio
0.937 xbrli:pure
0.972 xbrli:pure
0.869 xbrli:pure
0.141 xbrli:pure
0.950 xbrli:pure
Rate of return on equity
0.117 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
28.3 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
454,425,000 JPY
-363,482,000 JPY
-196,320,000 JPY
JPY
JPY
Net cash provided by (used in) investing activities
-11,099,000 JPY
-32,737,000 JPY
-250,000 JPY
JPY
JPY
Net cash provided by (used in) financing activities
1,486,235,000 JPY
1,544,285,000 JPY
368,201,000 JPY
JPY
JPY
Cash and cash equivalents
3,266,408,000 JPY
1,336,847,000 JPY
188,782,000 JPY
JPY
JPY
Number of employees
15 xbrli:pure
13 xbrli:pure
11 xbrli:pure
10 xbrli:pure
9 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.